Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women
Fei Ma, Jiong Wu, Fu Li, Anhua Li, Bo Lan, Kexin Chen, Jiangli Di, Yuxin Jiang, Jing Li, Ni Li, Ye‐Xiong Li, Peifang Liu, Jinsong Lu, Lijuan Niu, Weijun Peng, Songjie Shen, Jufang Shi, Qiang Sun, Zhongsheng Tong, Jing Wang, Yong Wang, Shusen Wang, Yuntao Xie, Jianming Ying, Jin Zhang, Kai Zhang, Zhihui Zhang, Ying Zheng, Qingli Zhu, Binghe Xu
Abstract
Breast cancer has become the most common malignant tumor worldwide. However, the survival rate of breast cancer patients in China is 8% lower compared to that in European and American countries. Insufficient screening coverage and low rate of early detection are key problems. Therefore, it is imperative to develop a set of guidelines for breast cancer screening, early diagnosis, and treatment strategies suitable for Chinese women. The National Health Commission, the National Cancer Center, and the National Cancer Quality Control Center collectively organized a committee of specialists with multidisciplinary backgrounds in breast surgery, oncology, radiotherapy, diagnostic imaging, ultrasound, pathology, epidemiology, and health economics. The committee collectively published "China Breast Cancer Screening, Early Diagnosis and Treatment Specification", in which the committee outlined a set of strategies of breast cancer screening, early diagnosis, and treatment suitable for China's national conditions. The strategies were formulated based on clinical experience in breast cancer prevention and treatment, characteristics of breast cancer patients in China, and socioeconomic conditions. The purpose of this article is to provide an interpretation of the above guidelines as a reference for breast cancer screening.